Group items tagged

A UK study has shown potential for a new blood test to diagnose human tuberculosis (TB) and identify those most at risk of developing the disease.

Patients with advanced non-small cell lung cancer (NSCLC) may soon be offered a blood test to assess their treatment options, instead of having to provide a tumour sample for analysis.

A research team led by the University of Strathclyde in the UK has developed an artificial intelligence (AI)-based blood test for the diagnosis of brain cancer.

A pharmacist in a leading independent pharmacy chain shares his myth-busting Ramadan advice on managing health and the use of medication while fasting. While the holy month means total fasting in terms of oral consumption, it's still ok, says Ifti Khan, superintendent pharmacist at Well Pharmacy, to have vaccinations and blood tests and to use eye drops or other medical items that are not ingested through the mouth. It's also important for people to keep taking their prescribed medication over the Ramadan period. Anyone who is concerned should speak to their pharmacist about whether they can take their medicine at different times, as stopping it could have serious consequences. Mr Khan, who will be observing Ramadan himself, said: "Confusion can sometimes arise when it comes to medication and managing health conditions whilst fasting", adding it is important for patients to keep managing health during Ramadan. Having injections or vaccinations is fine, as are blood tests, using eye or ear drops, and using anything that patients don't consume orally - so nicotine and other transdermal patches, pessaries and dialysis, for example. It's also ok to eat and drink as a result of a condition which causes forgetfulness.

National Institute for Health and Care Excellence (NICE)'s diagnostic advisory committee has recommended the use of HM-JACKarc or OC-Sensor quantitative faecal immunochemical tests (FIT) in a draft guidance release for consultation on Wednesday (5 July). Under existing NICE guidance, FIT was already offered to some people presenting to primary care with symptoms suggestive of colorectal cancer, while others were immediately referred on the suspected cancer pathway. The new draft guidance will now see everyone receive a FIT. A sample is sent in the post to a laboratory where the amount of blood in the faeces is measured. The results are usually available within a week and people with 10 or more micrograms of haemoglobin in their faeces should then be referred for further investigation. Further assessment using colonoscopy, or CT colonography, is required to diagnose cancer. The tests cost between £4 and £5 per sample, and can correctly identify about 9 out of 10 people with colorectal cancer. The committee agreed it is important that GPs can refer people for colonoscopy without a positive FIT result if they think it is necessary and where symptoms persist. The institute believes that the recommendation of the tests should reduce the number of unnecessary colonoscopies, thus freeing up appointments for more non-urgent referrals. This should lead to 50% fewer referrals for urgent colonoscopies being made by GPs in primary care settings each year.

NHS England has expanded its national bowel screening programme to people aged 54 so that cancers can be detected at an earlier stage when they are easier to treat. As part of the expansion, the health service would be sending a home-testing kit for bowel cancer, known as the Faecal Immunochemical Test (FIT), to thousands more people in the North West. Those who are eligible (aged 54 and over) will now automatically receive the kit every two years by post, enabling them to self-check for blood in stool samples, which can be a sign of bowel cancer. With the expansion of the NHS Bowel Cancer Screening Programme to people aged 54 years, an additional 830,000 people in England will now be eligible for the screening test.

The UK Health Security Agency (UKHSA) and the Office for National Statistics (ONS) will jointly launch a new study to gather data on COVID-19 this winter. The Winter COVID-19 Infection Study (WCIS) will run from November 2023 to March 2024, involving up to 200,000 participants, UKHSA has said on Monday (October 2). UKHSA previously commissioned the Coronavirus Infection Survey (CIS), conducted by the ONS in collaboration with scientific study leaders from Oxford University, analysing more than 11.5 million swab tests and 3 million blood tests from April 2020 to March 2023. Meanwhile, the Winter CIS study involves conducting up to 32,000 lateral flow tests weekly, providing vital insights into COVID-19 prevalence in the broader community. The sample will be structured to broadly reflect key population characteristics.

Get your thyroid test done from best path lab of Delhi NCR, Lifeline Laboratory. We provide home collection service in delhi NCR with the accurate report within a day

The number of people in England identified as at risk for type 2 diabetes mellitus (T2DM) has increased by over half a million within a year, according to NHS figures. Data released by the National Diabetes Audit on June 12 showed that 3.6 million people registered with a GP were found to have non-diabetic hyperglycaemia (also known as pre-diabetes) in 2023, compared with 3.1 million people in 2022 - a notable 18 per cent increase or nearly 550,000 people. Among those under 40 years old, the figures showed an increase of almost 25 per cent from 173,166 in 2022 to 216,440 in 2023. People with non-diabetic hyperglycaemia have higher-than-normal blood sugar levels, and they are at greater risk for developing type 2 diabetes and cardiovascular diseases. Typically, this condition is detected through routine blood tests at GP surgeries.

The microfluidics market is valued at 8.28 Billion in 2017 and is expected to grow at a CAGR of 22.6% during the forecast period, to reach to USD 27.91 Billion by 2023. Base year considered for the report is 2017 and the forecast period includes 2018 to 2023. The increasing incidence of other major chronic and infectious diseases, coupled with advancements in coagulation tests, blood gas electrolytes, hematology, urine chemistry, and cardiac markers, are creating new avenues for the growth of the POC diagnostics market. This, in turn, is expected to support the growth of the microfluidics market as POC testing is the largest segment of the microfluidics market for in vitro diagnostics.

A surrogate mother often faces criticism and judgment from others for the choice she have made. However, those are less problematic when compare to the risks that she takes for her own family, friends and spouse. These risks can be daunting and cause challenges she might not have considered before getting involved. These risks can be anything from medical and health concerns to finances and job security and often family and personal risks as well. Medical risk is a huge factor, when a woman becomes a surrogate often times, she and the donors would have to undergo intense examination. These exams range from blood, health tests to the initial process of the implanting of the eggs from the donor. In the beginning the clinic will bring her and the egg donor together to begin a lengthy process of sequencing ovulation cycles. The clinic would put the surrogate mother on birth control and steroids, such as Luprin. These medications are meant to get both the surrogate mother and the donor's cycles on the same schedule. This is crucial because the surrogates' uterus needs to be ready for the embryos. Just having to deal with the pain of insemination and testing can be unbearable, not to mention the unpleasant side effects from all the medication and actual insemination process. However, that is just part of it. The surrogates are also faced with depression, sleep disturbance, guilt and the difficulty to remain unattached. These factors alone cause many surrogates to face the fact that they are walking a long road that not many others might have the strength to do. Many clinics offer support groups and counseling. Aside from medical and emotional risks, there might also be legality issues with the laws of the state they reside in. What kind of laws protect the surrogate, what rights does she have to things such as privacy? And there are also finances to consider. Generally, surrogate mothers are responsible for all insurance costs. As a surrogate you should be financially

Researchers from the Max Planck Institute for Biology of Ageing in Germany and the Leiden University Medical Center (LUMC) in the Netherlands have discovered new blood biomarkers that could indicate a mortality risk in elderly people.

Chest pain is an alarming symptom that causes lot of anxiety and worry in people. From the Doctor's point of view, chest pain sets of a lot of alarms. Enter into the ER complaining of chest pain and the Doctor will rush you to the bed, strap an oxygen mask on you and order and ECG. While the ECG is being taken, he will draw a blood sample to test for Myocardial infarction. Though the above illustration may scare you, it's intention is not to scare but to educate on the seriousness with which chest pain is taken. However, in this article we aim to educate you on chest pain and how you can help when you or someone near you feels pain in the chest.

"Senior Citizen Welfare Association - Miryalaguda members and their families participated In the camp and the following tests- BP, Weight, Blood Sugar, ECG, 2D Echo were done free of cost. Cardiology Cardiothoracic Surgery, Orthopedic, Diabetic, Gen Medicine departments participated and gave free consultations. 175 members participated and Utilized the facilities. Dr AGK Gokhale addressed the gathering on "Better ways to lead healthy life". Senior Citizen Welfare Association - Miryalaguda has felicitated Dr AGK Gokhale on his remarkable achievements in Medical profession."